Literature DB >> 16120339

Optical function and mitochondrial metabolic properties in damage and recovery of bovine lens after in vitro carbonyl cyanide m-chlorophenylhydrazone treatment.

V Bantseev1, A P Cullen, J R Trevithick, J G Sivak.   

Abstract

In order to elucidate the correlation between lens optical function and metabolic function, in vitro bovine lens optical quality and mitochondrial integrity was measured following treatment with carbonyl cyanide m-chlorophenylhydrazone (the mitochondrial depolarizing agent, CCCP). The results indicate that in vitro exposure to CCCP resulted in concentration and time-dependent loss of sharp focus. The concentrations tested included 65.0, 32.5, 16.25 and 8.125 microm CCCP. Lenses treated with two lower concentrations show recovery from damage at the 24-h scan point. In lenses treated with 65 microM CCCP, mitochondria in lens epithelial and superficial cortical fibre cells appeared short and swollen. The results of this study indicate that lens optical function and mitochondrial integrity are closely correlated.

Entities:  

Year:  2003        PMID: 16120339     DOI: 10.1016/S1567-7249(03)00059-X

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  3 in total

1.  Menadione degrades the optical quality and mitochondrial integrity of bovine crystalline lenses.

Authors:  Kenneth W Olsen; Vladimir Bantseev; Vivan Choh
Journal:  Mol Vis       Date:  2011-01-26       Impact factor: 2.367

Review 2.  Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.

Authors:  Mark A Babizhayev
Journal:  BBA Clin       Date:  2016-04-19

Review 3.  Molecular Age-Related Changes in the Anterior Segment of the Eye.

Authors:  Luis Fernando Hernandez-Zimbron; Rosario Gulias-Cañizo; María F Golzarri; Blanca Elizabeth Martínez-Báez; Hugo Quiroz-Mercado; Roberto Gonzalez-Salinas
Journal:  J Ophthalmol       Date:  2017-09-24       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.